ERBB2 and aneurysmal bone cyst: The downregulation of HER2 induced by trastuzumab/pertuzumab combination was confirmed in vivo, by the immunohistochemical assessment of bioptic specimens from four trastuzumab/pertuzumab-treated ABC patients prior to and following exposure to double-block (Table 1).